MS: Busting the Myths
June 22, 2023 | Advocacy, Funding, Media, Progressive
Multiple Sclerosis New Zealand (MSNZ) is delighted to share that Pharmac have commenced consultation to fund Ocrelizumab for Primary Progressive MS. Currently, those with PPMS have no access to any disease modifying therapies. Ocrelizumab has been proven in trials to […]
May 30, 2023 | Advocacy, Awards, Media
Media release: Tuesday May 30th 2023 The health charity advocating for the more than 4100 New Zealanders living with multiple sclerosis (MS) has won a prestigious international award recognising its tireless eight year battle to have Pharmac widen access to […]
February 20, 2023 | Carers, Life with MS, Media
Multiple Sclerosis (MS), is a chronic, progressive condition that causes a host of symptoms, including vision loss, pain, fatigue, cognitive changes and impaired coordination. Many MS symptoms are unseen. The impact of MS on those diagnosed is life-changing and relentless. […]
November 16, 2022 | Advocacy, Life with MS, Media
Recently, MSNZ made a submission to the Accessibility for New Zealanders Bill. The intention of the proposed bill is to establish “a new legislative framework that addresses systemic accessibility barriers that prevent disabled people, tāngata whaikaha and their whānau, and […]
November 9, 2022 | Advocacy, Media
This morning, 9th November 2022, MSNZs President, Neil Woodhams and petition submitter, Joan Perry made an oral presentation to the Health Select Committee calling for them to make aHSCT an available treatment option in NZ. It was live streamed on […]